Cargando…
Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease
Biotin-thiamine responsive basal ganglia disease (BTBGD) is a rare metabolic condition caused by mutations in the SLC19A3 gene. BTBGD presents with encephalopathy and significant disease progression when not treated with biotin and/or thiamine. We present a patient of Mexican and European ancestry d...
Autores principales: | Sremba, L.J., Chang, R.C., Elbalalesy, N.M., Cambray-Forker, E.J., Abdenur, J.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121344/ https://www.ncbi.nlm.nih.gov/pubmed/27896110 http://dx.doi.org/10.1016/j.ymgmr.2014.07.008 |
Ejemplares similares
-
Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease
por: Whitford, Whitney, et al.
Publicado: (2017) -
Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease
por: Alfadhel, Majid, et al.
Publicado: (2017) -
Biotin-thiamine-responsive basal ganglia disease: A case report
por: Majumdar, Shamaita, et al.
Publicado: (2021) -
An unusually mild case of biotin-thiamine-responsive basal ganglia disease
por: Lail, Gurnoor, et al.
Publicado: (2023) -
Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy
por: Flønes, Irene, et al.
Publicado: (2016)